Table 2.
Repeated Measure ANOVAs for Predictors of Adolescent Internalizing Symptoms
| Measure | F | p | d |
|---|---|---|---|
| RCADS Depression | |||
| Cohort | 3.37 | .069 | 0.32 |
| Pre‐COVID Medication Status | 0.01 | .940 | 0.01 |
| Spring 2020 Medication Status | 2.01 | .159 | 0.25 |
| Summer 2020 Medication Status | 4.72 | .032 | 0.38 |
| Sex | 1.49 | .224 | 0.21 |
| Race/Ethnicity | 1.03 | .312 | 0.18 |
| Income | 0.25 | .616 | 0.09 |
| ADHD Status | 0.40 | .529 | 0.11 |
| Emotion Regulation | 20.97 | <.001 | 0.79 |
| ADHD × Emotion Regulation | 0.42 | .519 | 0.11 |
| RCADS Anxiety | |||
| Cohort | 8.99 | .003 | 0.52 |
| Pre‐COVID Medication Status | 5.05 | .026 | 0.39 |
| Spring 2020 Medication Status | 12.78 | <.001 | 0.62 |
| Summer 2020 Medication Status | 2.87 | .093 | 0.29 |
| Sex | 0.85 | .359 | 0.16 |
| Race/Ethnicity | 2.47 | .118 | 0.27 |
| Income | 0.08 | .778 | 0.06 |
| ADHD Status | 0.37 | .542 | 0.11 |
| Emotion Regulation | 37.22 | <.001 | 1.05 |
| ADHD × Emotion Regulation | 1.62 | .206 | 0.22 |
| Sluggish Cognitive Tempo | |||
| Cohort | 0.12 | .729 | 0.06 |
| Pre‐COVID Medication Status | 1.44 | .231 | 0.17 |
| Spring 2020 Medication Status | 2.21 | .138 | 0.21 |
| Summer 2020 Medication Status | 2.95 | .087 | 0.24 |
| Sex | 3.08 | .081 | 0.25 |
| Race/Ethnicity | 1.72 | .191 | 0.18 |
| Income | 0.00 | .951 | 0.01 |
| ADHD Status | 8.12 | .005 | 0.40 |
| Emotion Regulation | 33.34 | <.001 | 0.81 |
| ADHD × Emotion Regulation | 1.54 | .216 | 0.18 |
ADHD = attention‐deficit/hyperactivity disorder; RCADS = Revised Children's Anxiety and Depression Scale. Race/Ethnicity coded 1 = Black and/or Latinx, 0 = other. Medication statuses coded 1 = on medication at that timepoint, 0 = not on medication at that timepoint. Bolded rows represent significant coefficients. Coefficients for cohort and medication statuses were not interpreted to reduce risk of Type I Error.